Otolith Labs
Otolith Labs is pioneering the first therapeutic for vertigo and motion sickness, which affects upwards of 40 percent of the population, by building innovative technologies using ultrasound waves.
Otolith Labs is pioneering the first therapeutic for vertigo and motion sickness, which affects upwards of 40 percent of the population, by building innovative technologies using ultrasound waves.
